Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials

Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, JapanCorrespondence[email protected] [email protected]

Nobuyuki MiyasakaEmeritus Professor, Tokyo Medical and Dental University, Tokyo, Japan

Shinichi KawaiDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan

Hirotoshi YuasaPfizer Japan, Tokyo, Japan

Noriaki YamashitaPfizer Japan, Tokyo, Japan

Noriko SugiyamaPfizer Japan, Tokyo, Japan

Lorin Craig WagerlePfizer Inc, Collegeville, PA, USA

Bonnie VlahosPfizer Inc, Collegeville, PA, USA

Joseph WajdulaPfizer Inc, Collegeville, PA, USA

Your download is now in progress and you may close this window